Rejected from Cell Reports? The 7 Best Journals to Submit Next

Cell Reports has a broad scope across biology but still applies editorial standards. The journal wants technically sound research with clear experimental evidence and logical conclusions.

Common rejection patterns

"The experimental evidence doesn't fully support the conclusions." Cell Reports reviewers flag overstatement, missing controls, or gaps in the experimental logic. This is the most actionable type of rejection because the problems are fixable.

"The advance is too incremental." Your paper refines existing knowledge but doesn't change understanding meaningfully. Even at 25% acceptance, Cell Reports wants papers that advance the field, not just add data points.

"The paper would benefit from additional experiments." Cell Reports, unlike Cell or Molecular Cell, doesn't typically ask for 6 months of additional work. But if reviewers felt key experiments were missing, the editor may have decided the gap was too large.

"The topic is better suited to a specialty journal." Your biology is solid but very specialized. A developmental biology finding, for example, may be better served by Development or Developmental Cell.

1. PLOS Biology

PLOS Biology publishes biological research with broad implications and a commitment to open science. If Cell Reports rejected for insufficient novelty, PLOS Biology may value other aspects of your work: reproducibility, open data, or methodological rigor.

Best for: Biology with broad implications, open-science-focused research, and reproducibility-focused studies.

2. eLife

eLife publishes your paper with reviews attached, letting the community judge the work. For papers where Cell Reports' editorial decision felt subjective, eLife's transparent model provides a different evaluation framework.

Best for: Biology papers where you want transparency and community judgment.

3. EMBO Reports

EMBO Reports publishes concise molecular biology papers with functional insight. If your Cell Reports submission was a biology paper with clear conclusions but not enough experimental breadth for Cell Reports, EMBO Reports' shorter-format requirement may actually work in your favor.

Best for: Concise molecular biology, gene regulation, cell signaling, and cell biology findings.

4. PNAS

PNAS publishes across all sciences with a ~15% acceptance rate. For biology papers that Cell Reports found too incremental, PNAS may value the rigor and completeness differently. PNAS is particularly strong for papers that cross traditional discipline boundaries.

Best for: Rigorous biology across all subfields, interdisciplinary biological research.

5. Nature Communications

If your paper is strong enough for Cell Reports (IF ~8) but got rejected, Nature Communications (IF ~16) might seem ambitious, but its ~25% acceptance rate is the same. The editorial perspective is different, and papers sometimes find a home at Nature Communications that Cell Reports didn't accept.

Best for: Strong biological research that needs a broad-scope, high-impact home.

6. Journal of Cell Biology

JCB is published by Rockefeller University Press and focuses specifically on cell biology. If your paper is cell biology research that Cell Reports found too specialized, JCB provides a dedicated audience of cell biologists.

Best for: Cell biology specifically: membrane biology, organelle function, cell division, cytoskeleton, cell migration.

7. Your field-specific journal

If Cell Reports rejected for scope, go to the top journal in your field. Development for developmental biology, Plant Cell for plant biology, Journal of Immunology for immunological research. These journals' editors know the field context better than generalist editors, and they reach the audience that will actually use your findings.

Don't think of a specialty journal as a step down from Cell Reports. A paper in Development (IF ~4) read by every developmental biologist is often more impactful than a paper in Cell Reports (IF ~8) that developmental biologists might miss among the hundreds of papers across all fields published there each year.

Best for: Papers where the contribution is primarily important within one biological subfield.

Fix what reviewers flagged. Cell Reports provides specific reviewer feedback, even for rejected papers. If reviewers identified missing controls, statistical issues, or logical gaps, address these before submitting anywhere. The same problems will surface at other journals.

Consider the completeness question. If Cell Reports said the story was incomplete, ask yourself honestly: can I add the missing experiments in 1-2 months? If yes, do it. Cell Reports rejects are competitive at PLOS Biology, eLife, and PNAS, but they'll be even more competitive with the gaps filled.

Don't assume you need to go down in impact. Cell Reports (IF ~8) rejects are competitive at PLOS Biology (IF ~8), EMBO Reports (IF ~7), and Journal of Cell Biology (IF ~7). These aren't step-downs; they're lateral moves to journals with different editorial perspectives. Nature Communications (IF ~16) is even a step up if the science is strong.

Adjust your framing. PLOS Biology values open science and reproducibility. EMBO Reports values concise molecular biology. JCB values cell biology specifically. Rewrite your introduction and cover letter for each journal's audience.

Rejected for "insufficient novelty"? eLife (transparent review) or PNAS (values rigor over novelty) or your field's top journal.

Rejected for experimental gaps? Fix the gaps before resubmitting. Cell Reports reviewers are relatively specific about what's missing.

Rejected for scope? Go to your field-specific journal. It's a better fit, not a step down.

Run your manuscript through a free Manusights scan to check formatting, scope alignment, and experimental completeness before your next submission.